Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients
- Author
- BALDONCINI, R; FERRI, C; BELLINI, C; DESIDERI, G; DE ANGELIS, C; SANTUCCI, A
University La Sapienza, Institute of I Clinica Medica, Andrea Cesalpino Foundation, 00161 Rome, Italy - Source
Clinical and investigative medicine. = Médicine clinique et expérimentale. 1996, Vol 19, Num 1, pp 13-19 ; ref : 33 ref
- CODEN
- CNVMDL
- ISSN
- 0147-958X
- Scientific domain
- General medicine general surgery
- Publisher
- Canadian Medical Association, Toronto, ON
- Publication country
- Canada
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adulte Effet biologique Facteur digitalique endogène Hypertension artérielle Peptide ANP Plasma Urine Voie intraveineuse Appareil circulatoire pathologie Homme Hormone natriurétique Hormone peptide
- Keyword (en)
- Adult Biological effect Digitalis like factor Hypertension Atrial natriuretic peptide Plasma Urine Intravenous administration Cardiovascular disease Human Natriuretic hormone Peptide hormone
- Keyword (es)
- Adulto Efecto biológico Factor digitálico endógeno Hipertensión arterial Péptido ANP Plasma Orina Vía intravenosa Aparato circulatorio patología Hombre Hormona natriurética Hormona péptido
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B05 Arterial hypertension. Arterial hypotension / 002B12B05B Clinical manifestations. Epidemiology. Investigative techniques. Etiology
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3030049
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Clinical and investigative medicine\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. invest. med\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-958X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALDONCINI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"FERRI, C\";i:1;s:10:\"BELLINI, C\";i:2;s:11:\"DESIDERI, G\";i:3;s:13:\"DE ANGELIS, C\";i:4;s:11:\"SANTUCCI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNVMDL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Clinical and investigative medicine\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. invest. med\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-958X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALDONCINI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"FERRI, C\";i:1;s:10:\"BELLINI, C\";i:2;s:11:\"DESIDERI, G\";i:3;s:13:\"DE ANGELIS, C\";i:4;s:11:\"SANTUCCI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNVMDL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Clinical and investigative medicine\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. invest. med\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-958X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALDONCINI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"FERRI, C\";i:1;s:10:\"BELLINI, C\";i:2;s:11:\"DESIDERI, G\";i:3;s:13:\"DE ANGELIS, C\";i:4;s:11:\"SANTUCCI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNVMDL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Clinical and investigative medicine\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. invest. med\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-958X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALDONCINI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"FERRI, C\";i:1;s:10:\"BELLINI, C\";i:2;s:11:\"DESIDERI, G\";i:3;s:13:\"DE ANGELIS, C\";i:4;s:11:\"SANTUCCI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNVMDL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Clinical and investigative medicine\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. invest. med\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0147-958X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALDONCINI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"FERRI, C\";i:1;s:10:\"BELLINI, C\";i:2;s:11:\"DESIDERI, G\";i:3;s:13:\"DE ANGELIS, C\";i:4;s:11:\"SANTUCCI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNVMDL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:130:\"Plasma and urinary digitalis-like substance levels during arterial natriuretic peptide infusion in essential hypertensive patients\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
